Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...
South Korean researchers have identified why immune checkpoint inhibitors fail to work against brain tumors such as ...
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" ...
This work addresses an important evidence gap in the use of immune checkpoint inhibitors among patients with pre-existing ...
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...
Prostate tumors can vanish from the immune system’s radar. Now, scientists have found a way to strip away that disguise by changing the length of a single RNA molecule.
Researchers have uncovered a clue to why immune checkpoint inhibitors-cancer therapies that release the immune "brakes" exploited by tumors to evade attack-show limited efficacy in some brain tumors.
Morning Overview on MSN
An experimental Alzheimer’s immune therapy cleared its first safety trial with positive results
An experimental antibody designed to briefly block the immune checkpoint PD-L1 in the brain has cleared its first human ...
Summary: Researchers demonstrated that the success of anti-CTLA-4 immunotherapy against brain tumors does not depend on local ...
Immunotherapies, anti-cancer treatments that enhance the immune system's ability to kill cancer cells, have made notable ...
Immunotherapy is a groundbreaking approach in cancer treatment that empowers the body’s own immune system to recognize and ...
Cancer immunotherapy has revolutionized oncology, with immune checkpoint inhibitors (ICIs) becoming integral components of modern anti-cancer treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results